loader
Please Wait
Applying Filters...

Renejix CDMO Partner for Small Molecule Oral Dosage Forms Renejix CDMO Partner for Small Molecule Oral Dosage Forms

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for cep_2017_058___rev_01 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    INFAR S.A.

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 INFAR, S.A. Palafolls ES (1)

    filter

    01 Ebastine, Micronised and non-micronised (1)

    filter

    01 Spain (1)

    filter

    01 Valid (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    INFAR, S.A. Palafolls ES

    Contact Supplier
    • FDA
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag Spain
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Ebastine, Micronised and non-micronised

    PDF Supplier PDF
    URL Supplier Web Content
    CEP 2017-058 - Rev 01
    Valid
    Chemical
    2024-06-28
    2015
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for Certificates of Suitability (CEPs) for CEP 2017-058 - Rev 01 of Infar, S.a. Palafolls Es

    Looking for Certificates of Suitability (CEPs) for CEP 2017-058 - Rev 01 of Infar, S.a. Palafolls Es 1

    20

    Infar, S.a. Palafolls Es, based in Spain, is a pharmaceutical company that stands out with its certifications from FDA.

    One of their significant offerings is Ebastine, Micronised and non-micronised, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2017-058 - Rev 01

    This Chemical Type CEP, issued on June 28, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

    Substance Number 2015 associated with this CEP further emphasizes

    Post Enquiry
    POST ENQUIRY